Aurea Biotech Expands Its Role in the Aesthetic Market
Aurea Biotech proudly announces its role as the exclusive distributor for ATTIVA in the United States, a cutting-edge subdermal radiofrequency technology aimed at enhancing aesthetic procedures. This strategic move not only highlights Aurea Biotech's commitment to delivering high-quality and compliant products but also reinforces its dedication to innovative solutions within the beauty and healthcare industry.
Focus on Quality and Regulatory Compliance
CEO Jack McCarthy emphasizes the importance of both quality and regulatory adherence in the company's operational strategy. "Our expectation for all distribution partners involves stringent operational and regulatory compliance," McCarthy explains. This statement reveals how crucial it is for Aurea Biotech to maintain product integrity and support practitioners with proper training, aligning with U.S. regulatory standards.
A Commitment to Practitioner Support
Supporting practitioners is at the heart of Aurea Biotech's mission. The company ensures that professionals using ATTIVA receive comprehensive training and ongoing support, empowering them to provide the best care to their clients. By prioritizing this practitioner-education approach, Aurea Biotech looks to foster strong relationships within the aesthetics community.
Looking Ahead
Aurea Biotech appreciates the trust and loyalty of its customers and partners. The company's commitment to setting high standards within the industry will drive continued innovations and solutions that benefit both practitioners and their clients. With the exclusive distribution of ATTIVA, Aurea Biotech is poised to make significant contributions to the flourishing aesthetic market.
Contact Information
For any inquiries or further information, individuals can reach out directly to Aurea Biotech's customer service team. They welcome communication through their dedicated phone line at (855) 288-4828 or via email at attiva@aureabiotech.com.
Frequently Asked Questions
What is ATTIVA?
ATTIVA is an advanced subdermal radiofrequency technology used in various aesthetic procedures aimed at improving skin quality.
Who is the CEO of Aurea Biotech?
Jack McCarthy is the current CEO of Aurea Biotech, overseeing its operations and strategic direction.
Why is regulatory compliance important for Aurea Biotech?
Regulatory compliance ensures that all products meet safety and quality standards, which is vital for preserving customer trust and product integrity.
How can practitioners get training for ATTIVA?
Aurea Biotech provides comprehensive training to practitioners using ATTIVA, ensuring they are well-prepared and informed about proper use and techniques.
What should I do if I have further questions?
For any further questions, you can contact Aurea Biotech's support team directly at (855) 288-4828 or through their email for assistance.
